Low-Molecular-Weight Heparin
- 13 October 1998
- journal article
- review article
- Published by Wolters Kluwer Health in Circulation
- Vol. 98 (15) , 1575-1582
- https://doi.org/10.1161/01.cir.98.15.1575
Abstract
No abstract availableThis publication has 41 references indexed in Scilit:
- Low-Molecular-Weight HeparinsNew England Journal of Medicine, 1997
- A Comparison of Low-Molecular-Weight Heparin with Unfractionated Heparin for Acute Pulmonary EmbolismNew England Journal of Medicine, 1997
- Low-Molecular-Weight Heparin in the Treatment of Patients with Venous ThromboembolismNew England Journal of Medicine, 1997
- Heparin-Induced Thrombocytopenia in Patients Treated with Low-Molecular-Weight Heparin or Unfractionated HeparinNew England Journal of Medicine, 1995
- Clot-bound thrombin is protected from inhibition by heparin-antithrombin III but is susceptible to inactivation by antithrombin III-independent inhibitors.Journal of Clinical Investigation, 1990
- Heparin and Its Low Molecular Weight Derivatives: Anticoagulant and Antithrombotic PropertiesPathophysiology of Haemostasis and Thrombosis, 1986
- Structure-activity relationship in heparin: A synthetic pentasaccharide with high affinity for antithrombin III and eliciting high anti-factor Xa activityBiochemical and Biophysical Research Communications, 1983
- Effect of Heparin and Heparin Fractions on Platelet AggregationJournal of Clinical Investigation, 1980
- Highly active heparin species with multiple binding sites for antithrombinBiochemical and Biophysical Research Communications, 1979
- Factor‐Xa Inactivation by Antithrombin IIIBritish Journal of Haematology, 1973